Evotec grants licence to Roche Diagnostics:
This article was originally published in Clinica
Executive Summary
German company Evotec OAI has granted Roche Diagnostics a licence covering the melting curve analysis of investigated gene fragments in polymerase chain reactions (PCR). Hamburg-based Evotec says the use of its technology in instrumentation and kits increases the accuracy of data of diagnostic kits. Evotec will gain royalties on future product sales as well as milestone payments. Roche will apply the technology to its LightCycler technology.